Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice

BACKGROUND & AIMS: Endothelial precursor cell (EPC) dysfunction is one of the risk factors for diabetes mellitus (DM) which results in delayed wound healing. Rosiglitazone (RSG) is a frequently prescribed oral glucose-lowering drug. Previous studies have shown the positive effects of RSG on amel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guoliang, Han, Xue, Wu, Zhiheng, Shi, Qiaojuan, Bao, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800979/
https://www.ncbi.nlm.nih.gov/pubmed/31637120
http://dx.doi.org/10.7717/peerj.7815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800979/
https://www.ncbi.nlm.nih.gov/pubmed/31637120
http://dx.doi.org/10.7717/peerj.7815

Ejemplares similares